Panobinostat mediated cell death: a novel therapeutic approach for osteosarcoma

Osteosarcoma is an aggressive cancer with a poor long term prognosis. Neo-adjuvant poly-chemotherapy followed by surgical resection remains the standard treatment, which is restricted by multi-drug resistance. If first-line therapy fails, disease control and patient survival rate drop dramatically....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Wirries, André, Jabari, Samir, Jansen, Esther P., Roth, Silvia, Figueroa-Juárez, Elizabeth, Wissniowski, Thaddeus T., Neureiter, Daniel, Klieser, Eckhard, Lechler, Philipp, Ruchholtz, Steffen, Bartsch, Detlef K., Boese, Christoph K., Di Fazio, Pietro
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2018
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6152475/
https://ncbi.nlm.nih.gov/pubmed/30250645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26038
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items